Skip to content
← Full study record

NCT00248547 · MORE INFO

Limitations, agreements, and source contact

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant · Source last updated 2017-05-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
bubaloj@ohsu.edu
organization
Oregon Health & Science University, Knight Cancer Institute
phone
503-494-1054
title
Joseph Bubalo, PharmD
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
bubaloj@ohsu.edu
organization
Oregon Health & Science University, Knight Cancer Institute
phone
503-494-1054
title
Joseph Bubalo, PharmD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice